New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015

Martyna Maciów-Głąb; Karol Kula; Małgorzata Kłys; Sebastian D. Rojek

doi:10.5114/amsik.2017.71449

eISSN: 1689-1716
ISSN: 0324-8267

Archiwum Medycyny Sądowej i Kryminologii/Archives of Forensic Medicine and Criminology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2017
vol. 67

Send email

Copy url:

abstract:

Original paper

New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015

Martyna Maciów-Głąb

¹

,

Karol Kula

¹

,

Małgorzata Kłys

¹

,

Sebastian D. Rojek

¹

Chair and Department of Forensic Medicine, Jagiellonian University Medical College, Krakow, Poland

Arch Med Sadowej Kryminol 2017; 67 (3): 178-200

DOI: https://doi.org/10.5114/amsik.2017.71449

Online publish date: 2018/02/15

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Maciów-Głąb M, Kula K, Kłys M, Rojek S. New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015. Archiwum Medycyny Sądowej i  Kryminologii/Archives of Forensic Medicine and Criminology. 2017:178-200. doi:10.5114/amsik.2017.71449.

APA

Maciów-Głąb, M., Kula, K., Kłys, M.,  & Rojek, S. (2017). New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015. Archiwum Medycyny Sądowej i  Kryminologii/Archives of Forensic Medicine and Criminology, 178-200. https://doi.org/10.5114/amsik.2017.71449

Chicago

Maciów-Głąb, Martyna, Karol Kula, Małgorzata Kłys,  and Sebastian D. Rojek. 2017. "New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015". Archiwum Medycyny Sądowej i  Kryminologii/Archives of Forensic Medicine and Criminology: 178-200. doi:10.5114/amsik.2017.71449.

Harvard

Maciów-Głąb, M., Kula, K., Kłys, M.,  and Rojek, S. (2017). New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015. Archiwum Medycyny Sądowej i  Kryminologii/Archives of Forensic Medicine and Criminology, pp.178-200. https://doi.org/10.5114/amsik.2017.71449

MLA

Maciów-Głąb, Martyna et al. "New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015." Archiwum Medycyny Sądowej i  Kryminologii/Archives of Forensic Medicine and Criminology, 2017, pp. 178-200. doi:10.5114/amsik.2017.71449.

Vancouver

Maciów-Głąb M, Kula K, Kłys M, Rojek S. New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015. Archiwum Medycyny Sądowej i  Kryminologii/Archives of Forensic Medicine and Criminology. 2017:178-200. doi:10.5114/amsik.2017.71449.

PlumX metrics:

Aim of the study:
Aim of the study was to analyse of 2075 evidences containing new psychoactive substances (NPS).

Material and methods
The prepared samples were identified employing an analytical procedure where the analytes were investigated by gas chromatography-electron impact mass spectrometry (GC-EI-MS) using a created library of mass spectra.

Results
The analysis revealed the following substances in the investigated products: piperazine derivatives (including BZP, MPMP, TFMPP), cathinone derivatives (including: pentedrone, 3-MMC, butylone, 4-MEC), pyrovalerone derivatives (MDPV, naphyrone, α-PVP, α-PVT), synthetic cannabinoids (such as AM-2201, UR-144, XLR-11, JWH073, JWH081, PB-22, AB-CHMINACA). Research conducted in 2010–2015 made it possible to track changes in the composition of investigated preparations.

Conclusions
The following relationships has been shown: number of components decreased and in the end of 2015 dominated preparations with single component; introduction of amendments Act on Preventing Drug Addictionn affect the elimination from the market of one compounds and replacing them by their derivatives; since 2011 on the market of ‘legal highs’ we did not observe occurrence of compounds of piperazine group.

keywords:

New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015

Martyna Maciów-Głąb 1 , Karol Kula 1 , Małgorzata Kłys 1 , Sebastian D. Rojek 1

new psychoactive substances (NSP), GC-EI-MS, identification

Martyna Maciów-Głąb

¹

,

Karol Kula

¹

,

Małgorzata Kłys

¹

,

Sebastian D. Rojek

¹